Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  European Respiratory Journal

• Publication date

  2000-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1034/J.1399-3003.2000.16A08.XPMID 10933083
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Allergic lung responses are increased in prostaglandin H synthase-deficient mice.

  1999cited by this paper
• Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics.

  1999cited by this paper
• Treatment of asthma with drugs modifying the leukotriene pathway.

  1999cited by this paper
• Aspirin-induced asthma: advances in pathogenesis and management.

  1999cited by this paper
• Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics.

  1998cited by this paper
• Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma.

  1998cited by this paper
• Aspirin-triggered 15-epi-lipoxin A4 (ATL) generation by human leukocytes and murine peritonitis exudates: development of a specific 15-epi-LXA4 ELISA.

  1998cited by this paper
• Phosphorylation of cytosolic phospholipase A2 by IL-3 is associated with increased free arachidonic acid generation and leukotriene C4 release in human basophils.

  1998cited by this paper
• Aspirin-triggered 15-Epi-Lipoxin A4 (LXA4) and LXA4 Stable Analogues Are Potent Inhibitors of Acute Inflammation: Evidence for Anti-inflammatory Receptors

  1997cited by this paper
• Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity?

  1997cited by this paper
• Inflammatory cell populations in bronchial biopsies from aspirin-sensitive asthmatic subjects.

  1996cited by this paper
• Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics.

  1996cited by this paper
• Lipid mediator networks in cell signaling: update and impact of cytokines 1

  1996cited by this paper
• Human whole blood assays for inhibition of prostaglandin G/H synthases-1 and-2 using A23187 and lipopolysaccharide stimulation of thromboxane B2 production

  1996cited by this paper
• Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions.

  1995cited by this paper
• Leukotriene E4 and granulocytic infiltration into asthmatic airways.

  1993cited by this paper
• The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin.

  1993cited by this paper
• Nasal secretions in response to acetylsalicylic acid.

  1993cited by this paper
• Agonist-induced lipoxin A4 generation: Detection by a novel lipoxin A4-ELISA

  1993cited by this paper
• Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics.

  1992cited by this paper
• The effects of lipoxin A4 on airway responses in asthmatic subjects.

  1992cited by this paper
• Chapter 10 – Lipoxins: Bioactive Lipoxygenase Interaction Products

  1991cited by this paper
• Inhibition of leukotriene B4-induced neutrophil migration by lipoxin A4: structure-function relationships.

  1991cited by this paper
• Lipoxygenases and Their Products

  1991cited by this paper
• Lipoxin formation in human nasal polyps and bronchial tissue

  1990cited by this paper
• Identification of lipoxin A4 and its relationship to the sulfidopeptide leukotrienes C4, D4, and E4 in the bronchoalveolar lavage fluids obtained from patients with selected pulmonary diseases.

  1990cited by this paper
• Study of mediators of anaphylaxis in nasal wash fluids after aspirin and sodium metabisulfite nasal provocation in intolerant rhinitic patients.

  1987cited by this paper
• Leukotrienes and lipoxins: structures, biosynthesis, and biological effects.

  1987cited by this paper
• Intolerance to Aspirin: Clinical Studies and Consideration of its Pathogenesis

  1968cited by this paper

• Sputum Eosinophil and Macrophage Changes After Aspirin Challenge in Patients With Nonsteroidal Anti‐Inflammatory Drug–Exacerbated Respiratory Disease

  2025cites this paper
• Specialized Pro-Resolving Lipid Mediators in Pulmonary Diseases: Molecular and Therapeutic Implications

  2025cites this paper
• Omega-3 long-chain polyunsaturated fatty acids and their bioactive lipids: A strategy to improve resistance to respiratory tract infectious diseases in the elderly?

  2024cites this paper
• Aspirin Hypersensitivity in Patients With Atherosclerotic Cardiovascular Disease.

  2024cites this paper
• Unique effect of aspirin on local 15‐oxo‐eicosatetraenoic acid synthesis in asthma patients with aspirin hypersensitivity

  2024cites this paper
• Pro-resolving lipid mediators and therapeutic innovations in resolution of inflammation.

  2024cites this paper
• Epeleuton, a novel synthetic ω-3 fatty acid, reduces hypoxia/ reperfusion stress in a mouse model of sickle cell disease

  2023cites this paper
• The role of oxylipins in NSAID-exacerbated respiratory disease (N-ERD).

  2023cites this paper
• The effect of low-dose aspirin on aspirin triggered lipoxin, interleukin 1 beta, and prostaglandin E2 levels in periapical fluid: a double-blind randomized clinical trial

  2023cites this paper
• Lipoxins in inflammation

  2022cites this paper
• Inflammation resolution in environmental pulmonary health and morbidity.

  2022cites this paper
• What happens to basophils and tryptase, LXA4 and CysLTs during aspirin desensitization?

  2022influential citation
• Sex Differences in Otolaryngology: Focus on the Emerging Role of Estrogens in Inflammatory and Pro-Resolving Responses

  2021cites this paper
• Lipid-Derived Mediators are Pivotal to Leukocyte and Lung Cell Responses in Sepsis and ARDS

  2021cites this paper
• Resolution-Based Therapies: The Potential of Lipoxins to Treat Human Diseases

  2021influential citation
• Emerging Role of Phospholipase-Derived Cleavage Products in Regulating Eosinophil Activity: Focus on Lysophospholipids, Polyunsaturated Fatty Acids and Eicosanoids

  2021cites this paper
• New concepts for the pathogenesis and management of aspirin-exacerbated respiratory disease

  2021cites this paper
• Aspirin Actions in Treatment of NSAID-Exacerbated Respiratory Disease

  2021cites this paper
• Arachidonic Acid 15-Lipoxygenase: Effects of Its Expression, Metabolites, and Genetic and Epigenetic Variations on Airway Inflammation

  2021cites this paper
• NSAID-Exacerbated Respiratory Disease (NERD): From Pathogenesis to Improved Care

  2020cites this paper
• Dysregulated metabolism of polyunsaturated fatty acids in eosinophilic allergic diseases.

  2020cites this paper
• Lipidmediatoren und ihre Rolle bei Entzündungen und Allergien

  2020cites this paper
• Position Statement of the Spanish Society of Allergology and Clinical Immunology on Provocation Tests with Aspirin/Nonsteroidal anti-inflammatory drugs.

  2020cites this paper
• Dysregulated fatty acid metabolism in nasal polyp‐derived eosinophils from patients with chronic rhinosinusitis

  2019cites this paper
• Position Statement of the Spanish Society of Allergology and Clinical Immunology on Provocation Tests with Aspirin / Nonsteroidal anti-inflammatory drugs Short title : Oral , bronchial and nasal provocation tests with aspirin

  2019cites this paper
• Sinus Surgery Is Associated with a Decrease in Aspirin-Induced Reaction Severity in Patients with Aspirin Exacerbated Respiratory Disease.

  2019cites this paper
• Non-type 2 inflammation in severe asthma is propelled by neutrophil cytoplasts and maintained by defective resolution.

  2019cites this paper
• Towards targeting resolution pathways of airway inflammation in asthma

  2018cites this paper
• Aspirin-exacerbated respiratory disease: an update

  2017cites this paper
• The effect of allergen‐induced bronchoconstriction on concentration of 5‐oxo‐ETE in exhaled breath condensate of house dust mite‐allergic patients

  2017cites this paper
• United States Patent Serhan

  2017cites this paper
• Bronchoprotective mechanisms for specialized pro-resolving mediators in the resolution of lung inflammation.

  2017cites this paper
• Key mechanisms governing resolution of lung inflammation

  2016cites this paper
• DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation.

  2016cites this paper
• What we know about nonsteroidal anti-inflammatory drug hypersensitivity

  2016cites this paper
• Leukotriene Receptor Antagonists and FLAP Inhibitors

  2016cites this paper
• Systemic expression of inflammatory mediators in patients with chronic rhinosinusitis and nasal polyps with and without Aspirin Exacerbated Respiratory Disease.

  2016cites this paper
• A Aspirin-Exacerbated Respiratory Disease Baseline B Aspirin Reaction

  2016cites this paper
• Lipoxins, Resolvins, and the Resolution of Inflammation

  2016cites this paper
• Aspirin-Exacerbated Respiratory Disease--New Prime Suspects.

  2016cites this paper
• Aspirin or Nonsteroidal Anti-inflammatory Drug-Exacerbated Chronic Rhinosinusitis.

  2016cites this paper
• Increased Postexercise Lipoxin A4 Levels in Exhaled Breath Condensate in Asthmatic Children With Exercise-Induced Bronchoconstriction.

  2016cites this paper
• Lipid Mediators in Aspirin-Exacerbated Respiratory Disease.

  2016cites this paper
• The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution.

  2015cites this paper
• Pathophysiologie der chronischen Rhinosinusitis, konservative Therapieoptionen

  2015cites this paper
• Role of omega-3 fatty acids and their metabolites in asthma and allergic diseases.

  2015cites this paper
• Lipid mediators in the resolution of inflammation.

  2015cites this paper
• Nasal Immunity, Rhinitis, and Rhinosinusitis

  2015cites this paper
• Lipoxins and aspirin-triggered lipoxins in resolution of inflammation.

  2015cites this paper
• Innate immunity is a key factor for the resolution of inflammation in asthma

  2015cites this paper
• Pathophysiology of chronic rhinosinusitis, pharmaceutical therapy options

  2015cites this paper
• Assessment and mechanism of the refractory period in asthma

  2015cites this paper
• Mechanisms of aspirin hypersensitivity – What is known up to now

  2015cites this paper
• Resolution of acute inflammation in the lung.

  2014cites this paper
• Desensibilización al ácido acetil-salicílico como tratamiento para la enfermedad respiratoria exacerbada por antiinflamatorios no esteroides

  2014cites this paper
• Audit of nasal lysine aspirin therapy in recalcitrant aspirin exacerbated respiratory disease

  2014cites this paper
• Effect of aspirin desensitization on T-cell cytokines and plasma lipoxins in aspirin-exacerbated respiratory disease.

  2014cites this paper
• Fatty acids, inflammation, and asthma.

  2014cites this paper
• Desensitization to acetyl-salicylic acid as a treatment for non-steroid anti-inflammatory drugs (NSAIDs)-exacerbated respiratory disease

  2014cites this paper
• Lipoxin A 4 : a new direction in asthma

  2013cites this paper
• Upregulation of CD11b on eosinophils in aspirin induced asthma.

  2013cites this paper
• Exhaled breath condensate eicosanoid levels associate with asthma and its severity.

  2013cites this paper
• Lipoxin A4: a new direction in asthma therapy?

  2013cites this paper
• Aspirin-Intolerant Asthma: A Comprehensive Review of Biomarkers and Pathophysiology

  2013cites this paper
• Deciphering the role of n-3 polyunsaturated fatty acid-derived lipid mediators in health and disease

  2013cites this paper
• Clinical studies on the role of eicosanoids in the asthmatic airway inflammation

  2013cites this paper
• Biochemical pathogenesis of aspirin exacerbated respiratory disease (AERD).

  2013cites this paper
• Mechanisms of aspirin desensitization.

  2013cites this paper
• Pathogenesis of aspirin-exacerbated respiratory disease and reactions.

  2013cites this paper
• Oral Inflammatory Diseases and Systemic Inflammation: Role of the Macrophage

  2012cites this paper
• Role of imbalance of eicosanoid pathways and staphylococcal superantigens in chronic rhinosinusitis

  2012cites this paper
• Resolution of inflammation in asthma.

  2012cites this paper
• Functional studies of genes involved in pathogenesis of aspirin-induced asthma

  2012cites this paper
• Resolvin D1 and Resolvin E1 Promote the Resolution of Allergic Airway Inflammation via Shared and Distinct Molecular Counter-Regulatory Pathways

  2012cites this paper
• Paradigm shift in the pharmacological management of periodontal diseases.

  2012cites this paper
• Immunomodulatory treatments for aspirin exacerbated respiratory disease

  2012cites this paper
• Genetic variants of the arachidonic acid pathway in non‐steroidal anti‐inflammatory drug‐induced acute urticaria

  2012cites this paper
• Periodontal Hastalık ve Lipoksinler

  2012cites this paper
• Aspirin-Induced Asthma

  2012cites this paper
• Lipoxin A4 and 8-isoprostane in the exhaled breath condensate of children hospitalized for status asthmaticus*

  2012cites this paper
• Lipid mediator profiling in pulmonary disease.

  2011cites this paper
• Aspirin and NSAID Reactions: Diagnosis, Pathophysiology, and Management

  2011cites this paper
• Urinary concentrations of 15‐epimer of lipoxin A4 are lower in patients with aspirin‐intolerant compared with aspirin‐tolerant asthma

  2011cites this paper
• Die Rolle neuer „pro-resolving” Lipidmediatoren bei entzündlichen Lungenerkrankungen

  2010cites this paper
• Drug-induced and Iatrogenic Respiratory Disease

  2010cites this paper
• Reversed changes of lipoxin A4 and leukotrienes in children with asthma in different severity degree

  2010cites this paper
• Lipoxin and Aspirin-Triggered Lipoxins

  2010cites this paper
• Therapeutic Applicability of Anti-Inflammatory and Proresolving Polyunsaturated Fatty Acid-Derived Lipid Mediators

  2010cites this paper
• Molecular Circuits of Resolution in Airway Inflammation

  2010cites this paper
• Aspirin-sensitive respiratory disease.

  2009cites this paper
• Lipoxin A4 generation is decreased in aspirin‐sensitive patients in lysine‐aspirin nasal challenge in vivo model

  2009influential citation
• Lipoxins: resolutionary road

  2009cites this paper
• Chapter 24 – Leukotrienes and Lipoxins

  2009cites this paper
• Hypersensitivity to Aspirin and Non-Steroidal Antiinflammatory Drugs

  2009cites this paper
• Aspirin-Sensitive Asthma

  2009cites this paper
• Diagnosis of Aspirin Sensitivity in Aspirin Exacerbated Respiratory Disease

  2009cites this paper
• Toxicity and Drug Safety

  2009cites this paper
• 2. Aspirin-induced Asthma

  2009cites this paper
• Chapter 9 – Anti-inflammatory and antipyretic analgesics and drugs used in gout

  2009cites this paper
• Chapter 33 – Pathophysiology of Asthma

  2009cites this paper